Purification and characterization of the serum amyloid A3 enhancer factor.
Serum amyloid A (SAA) is a major acute-phase protein synthesized and secreted mainly by the liver. In response to acute inflammation, its expression may be induced up to 1000-fold, primarily as a result of a 200-fold increase in the rate of SAA gene transcription. We showed previously that cytokine-induced transcription of the SAA3 gene promoter requires a transcriptional enhancer that contains three functional elements: two CCAAT/enhancer-binding protein (C/EBP)-binding sites and a third site that interacts with a constitutively expressed transcription factor, SAA3 enhancer factor (SEF). Each of these binding sites as well as cooperation among their binding factors is necessary for maximum transcription activation by inflammatory cytokines. Deletion or site-specific mutations in the SEF-binding site drastically reduced SAA3 promoter activity, strongly suggesting that SEF is important in SAA3 promoter function. To further elucidate its role in the regulation of the SAA3 gene, we purified SEF from HeLa nuclear extracts to near homogeneity by using conventional liquid chromatography and DNA affinity chromatography. Ultraviolet cross-linking and Southwestern experiments indicated that SEF consisted of a single polypeptide with an apparent molecular mass of 65 kDa. Protein sequencing and antibody supershift experiments identified SEF as transcription factor LBP-1c/CP2/LSF. Cotransfection of SEF expression vector with SAA3-luciferase reporter resulted in approximately a 5-fold increase in luciferase activity. Interestingly, interleukin-1 treatment of SEF-transfected cells caused dramatic synergistic activation (31-fold) of the SAA3 promoter. In addition to its role in regulating SAA3 gene expression, we provide evidence that SEF could also bind in a sequence-specific manner to the promoters of the alpha(2)-macroglobulin and Aalpha-fibrinogen genes and to an intronic enhancer of the human Wilm's tumor 1 gene, suggesting a functional role in the regulation of these genes.
Bing
Z
Z
Department of Biochemistry and Molecular Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Reddy
S A
SA
Ren
Y
Y
Qin
J
J
Liao
W S
WS
D001665:Binding Sites; D004268:DNA-Binding Proteins / Q000032:analysis / Q000235:genetics / Q000302:isolation & purification; D004742:Enhancer Elements, Genetic / Q000235:genetics*; D005340:Fibrinogen / Q000235:genetics; D005786:Gene Expression Regulation; D017930:Genes, Reporter; D006367:HeLa Cells; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology; D009687:Nuclear Proteins / Q000302:isolation & purification; D011401:Promoter Regions, Genetic; D011485:Protein Binding; D016601:RNA-Binding Proteins; D017421:Sequence Analysis; D000685:Serum Amyloid A Protein / Q000235:genetics*; D014157:Transcription Factors / Q000235:genetics / Q000302:isolation & purification; D015533:Transcriptional Activation; D014162:Transfection; D000511:alpha-Macroglobulins / Q000235:genetics
D004268:DNA-Binding Proteins; D007375:Interleukin-1; D009687:Nuclear Proteins; D016601:RNA-Binding Proteins; C489625:SAA3P protein, human; D000685:Serum Amyloid A Protein; C501906:TFCP2 protein, human; D014157:Transcription Factors; D000511:alpha-Macroglobulins; D005340:Fibrinogen